Go Pro
→ The startup growing 23 times faster than Nvidia (From Brownstone Research) (Ad)tc pixel Free SVA Stock Alerts

Sernova (SVA) Competitors

Sernova logo
C$0.14 0.00 (0.00%)
As of 06/30/2026 03:57 PM Eastern
Compare

SVA vs. BCT, IPA, SCYB, COM, and NVH

Should you buy Sernova stock or one of its competitors? MarketBeat compares Sernova with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sernova include BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), and Novoheart (NVH). These companies are all part of the "biotechnology" industry.

How does Sernova compare to BriaCell Therapeutics?

BriaCell Therapeutics (CVE:BCT) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, media sentiment, valuation and risk.

Sernova's return on equity of 55.85% beat BriaCell Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
BriaCell TherapeuticsN/A N/A N/A
Sernova N/A 55.85%-119.26%

BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BriaCell TherapeuticsN/AN/AN/A-C$0.38N/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

In the previous week, BriaCell Therapeutics' average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score.

Company Overall Sentiment
BriaCell Therapeutics Neutral
Sernova Neutral

0.0% of Sernova shares are held by institutional investors. 12.1% of Sernova shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Sernova beats BriaCell Therapeutics on 5 of the 6 factors compared between the two stocks.

How does Sernova compare to ImmunoPrecise Antibodies?

Sernova (TSE:SVA) and ImmunoPrecise Antibodies (CVE:IPA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends.

ImmunoPrecise Antibodies has higher revenue and earnings than Sernova. ImmunoPrecise Antibodies is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/A-C$35.70M-C$0.04N/A
ImmunoPrecise AntibodiesC$19.47M8.33-C$22.19M-C$0.89N/A

Sernova's return on equity of 55.85% beat ImmunoPrecise Antibodies' return on equity.

Company Net Margins Return on Equity Return on Assets
SernovaN/A 55.85% -119.26%
ImmunoPrecise Antibodies N/A N/A N/A

0.0% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Sernova's average media sentiment score of 0.00 equaled ImmunoPrecise Antibodies'average media sentiment score.

Company Overall Sentiment
Sernova Neutral
ImmunoPrecise Antibodies Neutral

Summary

Sernova beats ImmunoPrecise Antibodies on 5 of the 8 factors compared between the two stocks.

How does Sernova compare to Scythian Biosciences?

Sernova (TSE:SVA) and Scythian Biosciences (CVE:SCYB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/A-C$35.70M-C$0.04N/A
Scythian BiosciencesN/AN/AN/AN/AN/A

Sernova's return on equity of 55.85% beat Scythian Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
SernovaN/A 55.85% -119.26%
Scythian Biosciences N/A N/A N/A

0.0% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Sernova's average media sentiment score of 0.00 equaled Scythian Biosciences'average media sentiment score.

Company Overall Sentiment
Sernova Neutral
Scythian Biosciences Neutral

Summary

Sernova beats Scythian Biosciences on 3 of the 4 factors compared between the two stocks.

How does Sernova compare to 138267 (COM.TO)?

138267 (COM.TO) (TSE:COM) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

In the previous week, 138267 (COM.TO)'s average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score.

Company Overall Sentiment
138267 (COM.TO) Neutral
Sernova Neutral

0.0% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

Sernova's return on equity of 55.85% beat 138267 (COM.TO)'s return on equity.

Company Net Margins Return on Equity Return on Assets
138267 (COM.TO)N/A N/A N/A
Sernova N/A 55.85%-119.26%

Summary

Sernova beats 138267 (COM.TO) on 3 of the 4 factors compared between the two stocks.

How does Sernova compare to Novoheart?

Sernova (TSE:SVA) and Novoheart (CVE:NVH) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability, media sentiment and institutional ownership.

Sernova's return on equity of 55.85% beat Novoheart's return on equity.

Company Net Margins Return on Equity Return on Assets
SernovaN/A 55.85% -119.26%
Novoheart N/A N/A N/A

0.0% of Sernova shares are held by institutional investors. 12.1% of Sernova shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Sernova's average media sentiment score of 0.00 equaled Novoheart'saverage media sentiment score.

Company Overall Sentiment
Sernova Neutral
Novoheart Neutral

Novoheart has higher revenue and earnings than Sernova. Novoheart is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/A-C$35.70M-C$0.04N/A
NovoheartC$423.50K236.08-C$7.17M-C$0.04N/A

Summary

Sernova and Novoheart tied by winning 4 of the 8 factors compared between the two stocks.

Get Sernova News Delivered to You Automatically

Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SVA vs. The Competition

Export
MetricSernovaBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$50.98MC$506.79MC$6.79BC$12.17B
Dividend Yield7.86%3.87%2.66%6.18%
P/E Ratio-3.383.1727.4335.73
Price / SalesN/A6,614.76537.9410.12
Price / Cash6.1513.1347.9982.29
Price / Book-4.9289.9411.024.47
Net Income-C$35.70M-C$96.07MC$3.57BC$299.09M
7 Day Performance-3.57%1.11%2.90%1.11%
1 Month Performance-18.18%2.82%3.71%-2.77%
1 Year Performance-6.90%79.18%34.39%35.41%

Sernova Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SVA
Sernova
N/AC$0.14
flat		N/A-12.9%C$50.98MN/AN/A1,959
BCT
BriaCell Therapeutics
N/AC$10.60
-3.8%		N/A+0.0%C$168.68MN/AN/A5
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%		N/A+0.0%C$162.08MC$19.47MN/A80
SCYB
Scythian Biosciences
N/AC$3.49
-5.9%		N/A+0.0%C$102.38MN/AN/AN/A
COM
138267 (COM.TO)
N/AN/AN/AN/AC$102.19MN/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:SVA) was last updated on 7/2/2026 by MarketBeat.com Staff.
From Our Partners
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Urgent exposé on the "Mar-a-Lago Trade"
Dr. David Eifrig, former Goldman Sachs VP and Senior Partner at Stansberry Research, has released an urgent ex...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Gold Is About to Do Something It Hasn’t in 90 Years
The U.S. Treasury still carries America's gold reserves at $42 per ounce — a price set generations ago. Buried...
US Gold Bureau | Sponsoredtc pixel
What Happens to Your Assets If You Die Without a Will?
Without a will, your state's intestacy laws decide how your assets are divided — a rigid formula that ignores ...
SmartAsset | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel